Replies to post #803312 on NorthWest Biotherapeutics Inc (NWBO)

[beartrap12]

To Bruce, this is very good info to know:

So, from MHRA’s own publication record, end-of-year timing does not block approvals.

DCVax-L is typically discussed as an advanced therapy / cell-based product class.

The December 2024 lists show approvals including biologics and vaccines (f.eks. ustekinumab products, bevacizumab, COVID vaccine), plus oncology drugs.

Many of us longs want to be here online when approval (IMO) happens, and I might have ignored this board more than usual through the holidays if you hadn't brought their calendar of working all-days-but-Christmas to light!
And thanks again to Eagle8 for bringing DanishDude's X post over here.

[learningcurve2020]

This is crack to AI. 😂